Imaizumi, Yoshitaka

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report

Cook, L. B., Fuji, S., Hermine, O., Bazarbachi, A., Ramos, J. C., Ratner, L., Horwitz, S., Fields, P., Tanase, A., Bumbea, H., et al. (2019) · Journal of Clinical Oncology

T-cell and Retrovirus StudiesViral-associated cancers and disorders

Cited by 267

Long-term study of indolent adult T-cell leukemia-lymphoma

Takasaki, Y., Iwanaga, M., Imaizumi, Y., Tawara, M., Joh, T., Kohno, T., Yamada, Y., Kamihira, S., Ikeda, S., Miyazaki, Y., et al. (2010) · Blood

T-cell and Retrovirus StudiesViral-associated cancers and disorders

Cited by 180

Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002

Ishida, T., Fujiwara, H., Nosaka, K., Taira, N., Abe, Y., Imaizumi, Y., Moriuchi, Y., Jo, T., Ishizawa, K., Tobinai, K., et al. (2016) · Journal of Clinical Oncology

T-cell and Retrovirus StudiesViral-associated cancers and disorders

Cited by 152

Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study Group

Itonaga, H., Tsushima, H., Imanishi, D., Hata, T., Doi, Y., Mori, S., Sasaki, D., Hasegawa, H., Matsuo, E., Nakashima, J., et al. (2014) · Leukemia Research

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 12